Yüklüyor......

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?

Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cioffi, Michele, Heeschen, Christopher
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Landes Bioscience 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/
https://ncbi.nlm.nih.gov/pubmed/22754787
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!